Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 8/2003

01-08-2003 | News

Suspension of the NIH ARDS Network fluids and catheters treatment trial

Author: François Lemaire

Published in: Intensive Care Medicine | Issue 8/2003

Login to get access

Excerpt

Recently, the National Heart, Lung, and Blood Institute (NHLBI) of the United States National Institutes of Health (NIH) suspended the "Fluids and Catheters Treatment Trial" (FACTT) conducted by the Acute Respiratory Distress Syndrome (ARDS) Network because concerns were raised regarding the safety of patients. This spectacular decision was taken after a federal office in charge of overseeing research involving human subjects, the Office for Humane Research Protection (OHRP) questioned the study design and patients' safety in another study previously conducted by the ARDS Network, a trial of mechanical ventilation with lower tidal volumes, completed and published with much publicity in 2001 [1]. A recent issue of the New England Journal of Medicine (3 April 2003) included several articles on the problems raised by this important crisis in the clinical research realm, for example, research with or without direct benefit to enrolled patients, safety of patients during clinical trials, consent to critical care research, surrogacy, control group in trials dealing with deadly diseases, and definition of "routine care." …
Literature
1.
Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308PubMed
2.
Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez-Mondejar E, Clementi E, Mancebo J, Factor P, Matamis D, Ranieri M, Blanch L, Rodi G, Mentec H, Dreyfuss D, Ferrer M, Brun-Buisson C, Tobin M, Lemaire F (1998) Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume Reduction in ARDS. Am J Respir Crit Care Med 158:1831–1838PubMed
3.
Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, Mazer CD, McLean RF, Rogovein TS, Schouten BD, Todd TRJ, Slutsky AS, and the Pressure- and Volume-Limited Ventilation Strategy Group (1998) Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med 338:355–361PubMed
4.
Steinbrook R (2003) How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome. N Engl J Med 348:1393–1401CrossRefPubMed
5.
Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166:1510–1514CrossRefPubMed
6.
Brower RG, Matthay M, Schoenfeld D (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials. Am J Respir Crit Care Med 166:1515–1517PubMed
7.
8.
Luce J (2003) California's new law allowing surrogate consent for clinical research involving subjects with impaired decision-making capacity Intensive Care Med 29:1024–1025
9.
Shalala D (2000) Protecting research subjects—–what must be done. N Engl J Med 343:808–810
10.
Steinbrook R (2002) Protecting research subjects—–the crisis at Johns Hopkins. N Engl J Med 346:716–720CrossRefPubMed
11.
Freeman B, Danner R, Banks S, Natanson C (2001) Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 164:190–192PubMed
12.
Lemaire F, Brun-Buisson C (2000) Are institutional review boards effective in safeguarding patients in intensive care units? Curr Opin Anesthesiol 13:195–200
13.
Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E, and The Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340:409–417
14.
Dreyfuss D, Saumon G (2002) Evidence-based medicine or fuzzy logic: what is best for ARDS management? Intensive Care Med 28:230–234
Metadata
Title
Suspension of the NIH ARDS Network fluids and catheters treatment trial
Author
François Lemaire
Publication date
01-08-2003
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 8/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1843-7

Other articles of this Issue 8/2003

Intensive Care Medicine 8/2003 Go to the issue

Experimental

Positive end-expiratory pressure modulates local and systemic inflammatory responses in a sepsis-induced lung injury model

Original

Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis

Brief Report

The systemic inflammatory response syndrome (SIRS) to identify infected patients in the emergency room

Original

Intravenous phosphate in the intensive care unit: More aggressive repletion regimens for moderate and severe hypophosphatemia

Correspondence

Severe community-acquired pneumonia caused by Panton-Valentine leukocidin-positive Staphylococcus aureus: first reported case in the United Kingdom

Seminal Studies in Intensive Care

The introduction of positive endexpiratory pressure into mechanical ventilation: a retrospective